| __timestamp | Bausch Health Companies Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 15635076 |
| Thursday, January 1, 2015 | 582800000 | 23943601 |
| Friday, January 1, 2016 | 455000000 | 23689111 |
| Sunday, January 1, 2017 | 366000000 | 41006114 |
| Monday, January 1, 2018 | 414000000 | 51379106 |
| Tuesday, January 1, 2019 | 471000000 | 32705593 |
| Wednesday, January 1, 2020 | 452000000 | 53274000 |
| Friday, January 1, 2021 | 465000000 | 85352000 |
| Saturday, January 1, 2022 | 529000000 | 51999000 |
| Sunday, January 1, 2023 | 604000000 | 59471000 |
Data in motion
In the ever-evolving pharmaceutical landscape, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Bausch Health Companies Inc. and Summit Therapeutics Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Bausch Health's R&D expenses surged by approximately 145%, peaking in 2023. This reflects a robust focus on expanding their product pipeline. In contrast, Summit Therapeutics, while showing a significant increase of around 280% in R&D spending, operates on a smaller scale, emphasizing targeted research initiatives. Notably, Summit's R&D expenses reached their zenith in 2021, marking a pivotal year for the company. This comparative analysis underscores the diverse approaches these companies take in navigating the competitive pharmaceutical industry, highlighting the importance of strategic R&D investments in driving future growth and innovation.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Summit Therapeutics Inc.
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Bausch Health Companies Inc.
Research and Development Expenses Breakdown: Alnylam Pharmaceuticals, Inc. vs Summit Therapeutics Inc.
Summit Therapeutics Inc. vs Exelixis, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Summit Therapeutics Inc. vs Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Summit Therapeutics Inc. and Ligand Pharmaceuticals Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Summit Therapeutics Inc. and Taro Pharmaceutical Industries Ltd.
Research and Development: Comparing Key Metrics for Apellis Pharmaceuticals, Inc. and Bausch Health Companies Inc.
Comparing Innovation Spending: Perrigo Company plc and Bausch Health Companies Inc.
Research and Development: Comparing Key Metrics for Bausch Health Companies Inc. and Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bausch Health Companies Inc. and Vericel Corporation
Analyzing R&D Budgets: Bausch Health Companies Inc. vs HUTCHMED (China) Limited